Breast cancer exhibits heterogeneous clinical behaviors according to intrinsic tumor subtypes which are defined based on their expression of ER, PR, and human epidermal growth factor receptor 2 (HER2)[28]. This evidence concerns the gene ERBB2 and neoplasm.